Immunome IMNM Offering Cost Included In Accounts Payable Accrued Expenses And Other Current Liabilities
Offering Cost Included In Accounts Payable Accrued Expenses And Other Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept imnm:OfferingCostIncludedInAccountsPayableAccruedExpensesAndOtherCurrentLiabilities.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's offering cost included in accounts payable accrued expenses and other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's offering cost included in accounts payable accrued expenses and other current liabilities?
- Immunome (IMNM) reported offering cost included in accounts payable accrued expenses and other current liabilities of $0 in Q1 2026.
- How has Immunome's offering cost included in accounts payable accrued expenses and other current liabilities changed year-over-year?
- Immunome's offering cost included in accounts payable accrued expenses and other current liabilities decreased by 100.0% year-over-year, from $270K to $0.
- What does offering cost included in accounts payable accrued expenses and other current liabilities mean?
- This represents capital-raising costs that have been incurred but not yet settled in cash, recorded within current liabilities. It provides visibility into pending cash outflows related to financing activities. Tracking this ensures that the full cost of capital raises is accounted for, even if the cash payment is deferred to a future period.